Bill Commons

TN SB 1495

enacted

Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

Tennessee · 114S1 · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did TN SB 1495 pass?

Yes. TN SB 1495 has been enacted into law. Latest recorded action (2026-05-18): Pub. Ch. 888

What is TN SB 1495 about?

TN SB 1495 is a bill in the 114S1 titled “Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.”.

Who sponsors TN SB 1495?

Haile is the primary sponsor of TN SB 1495.

Introduced
2026-01-13
Latest action
2026-05-18 — Pub. Ch. 888
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Haileprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-05-18

    Pub. Ch. 888

  2. 2026-05-18

    Effective date(s) 05/05/2026

  3. 2026-05-05

    Signed by Governor.

    executive-signature

  4. 2026-04-23

    Transmitted to Governor for action.

    executive-receipt

  5. 2026-04-21

    Signed by Senate Speaker

    passage

  6. 2026-04-21

    Signed by H. Speaker

    passage

  7. 2026-04-20

    Enrolled and ready for signatures

    enrolled

  8. 2026-04-16

    Subst. for comp. HB.

    substitution

  9. 2026-04-16

    Passed H., Ayes 87, Nays 0, PNV 1

    passage

  10. 2026-02-23

    Rcvd. from S., held on H. desk.

  11. 2026-02-19

    Passed Senate, Ayes 31, Nays 0

    passage

  12. 2026-02-19

    Engrossed; ready for transmission to House

    receipt

  13. 2026-02-17

    Placed on Senate Consent Calendar 2 for 2/19/2026

  14. 2026-02-10

    Recommended for passage, refer to Senate Calendar Committee

  15. 2026-02-03

    Placed on Senate Judiciary Committee calendar for 2/10/2026

  16. 2026-01-14

    Passed on Second Consideration, refer to Senate Judiciary Committee

    referral-committee

  17. 2026-01-13

    Introduced, Passed on First Consideration

    introduction

  18. 2025-12-23

    Filed for introduction

    filing

Versions

Documents

Votes

  • SENATE JUDICIARY COMMITTEE: Recommended for passage, refer to Senate Calendar Committee 2/10/2026 Passed

    2026-02-10 · pass · 8-0

  • FLOOR VOTE: Motion to Adopt 2/19/2026 Passed

    2026-02-19 · pass · 31-0

  • FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/16/2026 Passed (1)

    2026-04-16 · pass · 87-0

    Member-level votes (1)
    • Reneau: not voting

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:32:51.339172Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TN&identifier=SB 1495. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.